Scorr-Insert
X

Overview of Alprazolam

Client Email Product
Alprox
  • Synopsis

  • Chemistry

PharmaCompass
API SUPPLIERS
API Suppliers

API Suppliers

US DMFs Filed

US DMFs Filed

CEP/COS Certifications

CEP/COS Certifications

JDMFs Filed

JDMFs Filed

Other Certificates

Other Certificates

Other Suppliers

Other Suppliers

API REF. PRICE (USD / KG)
629

API Market Place

INTERMEDIATES
DOSSIERs
USA (Orange Book)

USA (Orange Book)

Europe

Europe

Canada

Canada

Australia

Australia

South Africa

South Africa

Uploaded Dossiers

Uploaded Dossiers

GLOBAL SALES (USD Million)

U.S. Medicaid

Annual Reports

Dossiers Market Place

EXCIPIENTS
PATENTS & EXCLUSIVITIES

USFDA Orange Book Patents

0

USFDA Exclusivities

0

MEDIA

Blog

News

REFERENCE STANDARD

EDQM

USP

JP

0

Other Listed Suppliers

SERVICES

0

  • WHO-GMP
Applications: Ready mix Film coating system for moisture sensitive APIs
Ingredient(s): Stearic Acid
Dosage Form: Capsule, Tablet
Route of Administration (Grade): Oral
Pharmacopoeia Reference: USP / EP / JP; Having US-DMF
Technical Specifications: Moisture barrier film coating system
  • WHO-GMP
Applications: Enteric/ Delayed Release Coating
Dosage Form: Capsule, Tablet
Route of Administration (Grade): Solid Oral
Pharmacopoeia Reference: Multicompendial
Technical Specifications: Methylacryli acid and Ethyl Acrylate copolymer dispersion ( 1:1) Dispersion 30 percent
  • FDA
Applications: Film Forming Agent, Wet/Dry Granulation- Binder,Thickening & Suspension Agent, Non-Gelatin Capsule Manufacturing & Enteric Film Coating Systems
Dosage Form: Capsule, Tablet
Route of Administration (Grade): Not Available
Pharmacopoeia Reference: USP, EP, and JP
Technical Specifications: Not Available
  • FDA
  • EDQM
Applications: Controlled Release, Direct Compression,Wet Granulation,Tablet Coating, Liquid Solutions and Suspensions
Dosage Form: Tablet, Capsule
Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Not Available
Technical Specifications: Not Available
  • WHO-GMP
Applications: Enteric/ Delayed Release Matrix and Solubility Enhancement
Dosage Form: Capsule, Tablet
Route of Administration (Grade): Solid Oral
Pharmacopoeia Reference: Multicompendial
Technical Specifications: Methylacryli acid and Ethyl Acrylate copolymer (1:1) Type A
  • FDA
Applications: Sustained Release Tablet Matrix
Dosage Form: Capsule, Tablet
Route of Administration (Grade): Not Available
Pharmacopoeia Reference: USP, EP, and JP
Technical Specifications: Not Available
  • FDA
Applications: Immediate Release
Ingredient(s): Starch
Dosage Form: Tablet
Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Customized per requirements
Technical Specifications: Not Available
  • WHO-GMP
Applications: Ready mix Non-Functional film coating system.
Dosage Form: Capsule, Tablet
Route of Administration (Grade): Oral
Pharmacopoeia Reference: USP / EP / JP; Having US-DMF
Technical Specifications: Ready mix Non-Functional film coating system
  • FDA
Applications: Immediate Release
Dosage Form: Tablet
Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Customized per requirements
Technical Specifications: Not Available
  • FDA
Applications: Immediate Release
Dosage Form: Tablet
Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Customized per requirements
Technical Specifications: Not Available
left grey arrow
right gray arrow
  • TABLET;ORAL - 0.25MG
  • TABLET;ORAL - 0.5MG
  • TABLET;ORAL - 1MG
  • TABLET;ORAL - 2MG
  • TABLET, EXTENDED RELEASE;ORAL - 0.5MG
  • TABLET, EXTENDED RELEASE;ORAL - 1MG
  • TABLET, EXTENDED RELEASE;ORAL - 2MG
  • TABLET, EXTENDED RELEASE;ORAL - 3MG
  • TABLET, ORALLY DISINTEGRATING;ORAL - 0.25MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
  • TABLET, ORALLY DISINTEGRATING;ORAL - 0.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
  • TABLET, ORALLY DISINTEGRATING;ORAL - 1MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
  • TABLET, ORALLY DISINTEGRATING;ORAL - 2MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty